Neuphoria Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period
Neuphoria Therapeutics Inc. (NEUP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period of -27.14 thousand shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod · last filed 2026-09-18
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for the quarter ending 2026-06-30 was -313.00 shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for the quarter ending 2026-03-31 was -20.55K shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for the quarter ending 2025-12-31 was -257.00 shares, a 100.00% decline year-over-year.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for the quarter ending 2025-09-30 was -6.02K shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2026 was -27.14K shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2025 was -416.00 shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2024 was -922.60K shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2023 was -1.45M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | -313.00 shares derived: 10-K 12 month − 3 quarters · filed 2026-09-18 | -20.86K shares derived: sum of 2 quarters · filed 2026-09-18 | -21.12K shares derived: sum of 3 quarters · filed 2026-09-18 | -27.14K shares 10-K · filed 2026-09-18 |
| 2026-03-31 | -20.55K shares 10-Q · filed 2026-05-15 | -20.80K shares derived: sum of 2 quarters · filed 2026-05-15 | -26.83K shares derived: sum of 3 quarters · filed 2026-05-15 | -26.97K shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -257.00 shares 10-Q · filed 2026-05-15 | -6.28K shares derived: sum of 2 quarters · filed 2026-05-15 | -6.42K shares derived: sum of 3 quarters · filed 2026-05-15 | -6.42K shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-09-30 | -6.02K shares 10-Q · filed 2026-05-15 | -6.17K shares derived: sum of 2 quarters · filed 2026-05-15 | -6.17K shares derived: sum of 3 quarters · filed 2026-05-15 | 13.01M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -143.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | -143.00 shares derived: sum of 2 quarters · filed 2025-09-29 | 13.01M shares derived: sum of 3 quarters · filed 2025-09-29 | -416.00 shares 10-K · filed 2025-09-29 |
| 2025-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-20 | 13.01M shares derived: sum of 2 quarters · filed 2025-05-20 | -273.00 shares 10-Q · filed 2025-05-20 | |
| 2024-12-31 | 13.01M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | -273.00 shares 10-Q · filed 2025-02-14 | ||
| 2024-09-30 | -13.02M shares 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | -922.60K shares 10-K · filed 2024-09-30 | |||
| 2023-06-30 | -1.45M shares 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |